Magenta Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Magenta Therapeutics Inc
TickerDNTH
CIK #0001690585
CUSIP252828108
SectorLife Sciences - Pharmaceutical Preparations
Address50 Hampshire Street, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001690585] 10-K
[0001690585] 10-Q
[0001690585] 3
[0001690585] 4
[0001690585] 5
[0001690585] 8-K
[0001690585] D
[0001690585] SC 13D
[0001690585] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Dianthus Therapeutics Inc /DE/ [2025-05-15] 0.0
Point72 Asset Management LP Dianthus Therapeutics Inc /DE/ [2025-04-17] 0.0
Deep Track Capital LP Dianthus Therapeutics Inc /DE/ [2025-03-24] 0.0
TCG Crossover GP II LLC Dianthus Therapeutics Inc /DE/ [2024-11-22] 81945.1
BlackRock Inc Dianthus Therapeutics Inc /DE/ [2024-11-08] 5.6
BlackRock Inc Dianthus Therapeutics Inc /DE/ [2024-10-24] 5.6
Octagon Capital Advisors LP Dianthus Therapeutics Inc /DE/ [2024-10-11] 6.0
BCLS Fund III Investments LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 81949.99
RA Capital Management LP Dianthus Therapeutics Inc /DE/ [2024-02-02] 9.99
Avidity Partners Management LP Dianthus Therapeutics Inc /DE/ [2024-01-31] 0.9
FMR LLC Dianthus Therapeutics Inc /DE/ [2023-11-13] 0.0
Venrock Healthcare Capital Partners III LP Dianthus Therapeutics Inc /DE/ [2023-09-21] 6.3
5AM Partners VII LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 7.1
Viridian LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 8194.0
Fairmount Funds Management LLC Dianthus Therapeutics Inc /DE/ [2023-09-21] 819412.7
Citadel Advisors LLC Magenta Therapeutics Inc [2023-05-15] 6.5
Tang Capital Partners LP Magenta Therapeutics Inc [2023-02-13] 9.7
RA Capital Management LP Magenta Therapeutics Inc [2022-09-26] 6.09
Aquilo Capital Management LLC Magenta Therapeutics Inc [2022-02-14] 5.4
Deep Track Capital LP Magenta Therapeutics Inc [2021-05-14] 7.14
Atlas Venture Fund X LP Magenta Therapeutics Inc [2020-07-14] 8.7
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2020-02-14] 10.52
Gilder Gagnon Howe & Co LLC Magenta Therapeutics Inc [2019-06-10] 10.6
Third Rock Ventures GP IV LP Magenta Therapeutics Inc [2019-02-13] 24.2
Eventide Asset Management LLC Magenta Therapeutics Inc [2019-02-13] 8.0
Atlas Venture Fund X LP Magenta Therapeutics Inc [2019-02-13] 14.6
GV 2016 LP Magenta Therapeutics Inc [2019-02-12] 10.07
Casdin Capital LLC Magenta Therapeutics Inc [2018-07-02] 5.9
Form 3/4/5 Filer 2011 - 2025
Lawton Alison Frances
Dianthus Therapeutics, Inc. /DE/
McGeorge Anne
Read Simon
Violin Jonathan
Soteropoulos Paula
Romano Steven J.
Kango Sujay
Savitz Ryan
Veness Adam M
Randhawa Simrat
Garcia Marino
Carr Edward
Kiselak Tomas
Fairmount Funds Management LLC
Moulder Leon O Jr
Witzke David Roy
Meng Lei
Gregory Michael David
Avidity Partners Management (GP) LLC
Avidity Partners Management LP
Harwin Peter Evan
TRV GP IV LLC
Third Rock Ventures GP IV, L.P.
Third Rock Ventures IV, L.P.
Stants Kristen
Beetham Thomas W.
Mahoney Stephen F.
Deardorf Caren
Gardner Jason
Vasconcelles Michael
Olson Lisa
Humphrey Jeffrey
Nichols David Wayne
Scadden David
Booth Bruce
Daniel Thomas O
Ronneberg Amy L
Albers Jeffrey W.
Borisy Alexis
Bonney Michael W
Atlas Venture Fund X, L.P.
Davis John C Jr
Zdraveski Zoran
Driscoll Cindy
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Associates Opportunity I, L.P.
Atlas Venture Opportunity Fund I, L.P.
Byers Blake
Isacson Christina K
Ryan Jason
Cooke Michael P
Atlas Venture Associates X, LLC
Atlas Venture Associates X LP
GV 2016 GP LLC
GV 2016 GP LP
Alphabet Inc.
GV 2016 LP
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 4,543,779 4,544,188
Vestal Point Capital LP [2025-06-30] SOLE 3,200,000 3,200,000
RA Capital Management LP [2025-06-30] SOLE 2,866,733 2,866,733
Fairmount Funds Management LLC [2025-06-30] SOLE 2,707,191 2,707,191
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 2,482,250 2,482,250
Octagon Capital Advisors LP [2025-06-30] SOLE 2,341,667 2,341,667
Deep Track Capital LP [2025-06-30] SOLE 2,233,148 2,233,148
Avidity Partners Management LP [2025-06-30] SOLE 1,742,902 1,742,902
TCG Crossover Management LLC [2025-06-30] SOLE 1,501,624 1,501,624
Vanguard Group Inc [2025-06-30] SOLE 0 1,430,723
Point72 Asset Management LP [2025-06-30] DFND 0 1,392,517
BlackRock, Inc. [2025-06-30] SOLE 1,321,062 1,358,781
AllianceBernstein LP [2025-06-30] DFND 1,140,275 1,174,822
VR Adviser LLC [2025-06-30] SOLE 1,000,000 1,000,000
5AM Venture Management LLC [2025-06-30] SOLE 984,725 984,725
State Street Corp [2025-06-30] DFND 799,521 820,137
Baker Bros Advisors LP [2025-06-30] SOLE 789,759 789,759
Catalio Capital Management LP [2025-06-30] SOLE 746,527 746,527
Citadel Advisors LLC [2025-06-30] DFND 665,044 665,044
Geode Capital Management LLC [2025-06-30] DFND 484,900 484,900
Woodline Partners LP [2025-06-30] SOLE 400,504 400,504
Goldman Sachs Group Inc [2025-06-30] DFND 364,587 364,592
Tang Capital Management LLC [2025-06-30] OTR 0 264,692
Candriam S.C.A. [2025-06-30] SOLE 240,576 240,576
SIO Capital Management LLC [2025-06-30] SOLE 236,070 236,070
Alphabet Inc. [2025-06-30] DFND 0 208,697
Millennium Management LLC [2025-06-30] SOLE 195,357 195,357
Adage Capital Partners GP LLC [2025-06-30] SOLE 185,000 185,000
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 172,039 172,039
Bank of America Corp /DE/ [2025-06-30] DFND 6,738 165,125
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com